Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The cancer-specific lncRNA LISR customizes ribosomes to suppress antitumour immunity

ABSTRACT: We report the changes in translatome of a melanoma line upon knock down of LISR

ORGANISM(S): Homo sapiens

PROVIDER: GSE222143 | GEO | 2025/09/10

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

The cancer-specific lncRNA LISR customizes ribosomes to suppress antitumour immunity

Project description:The cancer-specific lncRNA LISR customizes ribosomes to suppress antitumour immunity

| PRJNA918368 | ENA

The generation of cancer-specific ribosomes by the lncRNA LISR suppresses melanoma anti-tumour immunity

Project description:Gains of chromosome 12p11.21, encoding for the cancer-specific lncRNA LISR, correlate with poor survival in the PanCancer Atlas. In melanoma, LISR is highly expressed by patients resistant to immunotherapy and it contributes to the generation of drug-tolerant persister cells by activating an immune suppressive translational program affecting the synthesis of PD-L1 and of the glycocalyx. Interestingly, the use of glycans to evade the immune system is a characteristic of the sperm. Accordingly, a defective glycocalyx assembly during spermatogenesis causes infertility. Here we show that LISR affects the core ribosome composition and recruits Deleted in AZoospermia Associated Protein 1 (DAZAP1) to regulate an immune suppressive translational program that includes PD-L1 and several glycosylases. Consequently, down-regulation of LISR leads to robust anti-tumour immune responses and re-sensitizes to immune checkpoint blockade. Our study reveals the contribution of lncRNAs to the generation of cancer-specific ribosomes and identifies an RNA-based cancer-specific strategy to overcome intrinsic resistance to immune checkpoint +blockade.

2025-09-17 | PXD046528 | Pride

Project description:knock down of NRF2 in melanoma

| PRJNA601317 | ENA

Homo sapiens

Project description:knock down of NRF2 in melanoma

| PRJNA600181 | ENA

Reprogramming the translatome during daily light transitions is affected by cytosolic glyceraldehyde-3-phosphate dehydrogenase GAPC1/C2

Project description:translatome remodeling in A. thaliana GapC1/C2 knock down plants

| PRJEB72035 | ENA

Homo sapiens

Project description:NFATC2 knock-down on melanoma cell line A375

| PRJNA388509 | ENA

Cancer cell metabolism and antitumour immunity.

Project description:Accumulating evidence suggests that metabolic rewiring in malignant cells supports tumour progression not only by providing cancer cells with increased proliferative potential and an improved ability to adapt to adverse microenvironmental conditions but also by favouring the evasion of natural and therapy-driven antitumour immune responses. Here, we review cancer cell-intrinsic and cancer cell-extrinsic mechanisms through which alterations of metabolism in malignant cells interfere with innate and adaptive immune functions in support of accelerated disease progression. Further, we discuss the potential of targeting such alterations to enhance anticancer immunity for therapeutic purposes.

| S-EPMC11365797 | biostudies-literature

Homo sapiens

Project description:TYRP1 knock-down in human melanoma cell line (501Mel)

| PRJNA289013 | ENA

RNA-sequencing of RNAs found on eRpL22 paralogue-specific ribosomes in Drosophila melanogaster testis

Project description:This study uncovers a population of eRpL22 paralogue-specific specialized ribosomes in the fly testis. Wildtype testes were used to isolate eRpL22 paralogue-specific ribosomes complexed with RNA molecules. RNA-sequencing determined the distribution of RNAs (mRNA and ncRNA) on each type of eRpL22 paralogue-specific ribosome, revealing unique translatomes for both eRpL22- and eRpL22-like- ribosomes, as well as an overlapping translatome.

2019-06-14 | GSE124371 | GEO

NFATC2 knock-down on melanoma cell line A375

Project description:RNA-seq on NFATC2 knock-down (siRNA) on melanoma cell line A375

2017-09-29 | GSE99466 | GEO